Bring It on Again: Antimicrobial Stewardship in Transplant Infectious Diseases: Updates and New Challenges

Overview

Journal Antimicrob Steward Healthc Epidemiol

Publisher Cambridge University Press

Specialty Infectious Diseases

Date 2024 Jan 18

PMID 38234416

Authors

Helen Tsai

Rachel Bartash

Daniel Burack

Neeraja Swaminathan

Miranda So

Affiliations

Soon will be listed here.

Abstract

Advancement in solid organ transplantation and hematopoietic stem cell transplant continues to improve the health outcomes of patients and widens the number of eligible patients who can benefit from the medical progress. Preserving the effectiveness of antimicrobials remains crucial, as otherwise transplant surgeries would be unsafe due to surgical site infections, and the risk of sepsis with neutropenia would preclude stem cell transplant. In this review, we provide updates on three previously discussed stewardship challenges: febrile neutropenia, infection, and asymptomatic bacteriuria. We also offer insight into four new stewardship challenges: the applicability of the "shorter is better" paradigm shift to antimicrobial duration; antibiotic allergy delabeling and desensitization; colonization with multidrug-resistant gram-negative organisms; and management of cytomegalovirus infections. Specifically, data are accumulating for "shorter is better" and antibiotic allergy delabeling in transplant patients, following successes in the general population. Unique to transplant patients are the impact of multidrug-resistant organism colonization on clinical decision-making of antibiotic prophylaxis in transplant procedure and the need for antiviral stewardship in cytomegalovirus. We highlighted the expansion of antimicrobial stewardship interventions as potential solutions for these challenges, as well as gaps in knowledge and opportunities for further research.

References

Prohaska L, Mahmoudjafari Z, Shune L, Singh A, Lin T, Abhyankar S . Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant. Hematol Oncol Stem Cell Ther. 2018; 11(4):233-240. DOI: 10.1016/j.hemonc.2018.05.001. View

de Jonge N, Sikkens J, Zweegman S, Beeker A, Ypma P, Herbers A . Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial. Lancet Haematol. 2022; 9(8):e563-e572. DOI: 10.1016/S2352-3026(22)00145-4. View

Kawecki D, Wszola M, Kwiatkowski A, Sawicka-Grzelak A, Durlik M, Paczek L . Bacterial and fungal infections in the early post-transplant period after kidney transplantation: etiological agents and their susceptibility. Transplant Proc. 2014; 46(8):2733-7. DOI: 10.1016/j.transproceed.2014.09.115. View

Hengel R, Ritter T, Nathan R, Van Anglen L, Schroeder C, Dillon R . Real-world Experience of Bezlotoxumab for Prevention of Infection: A Retrospective Multicenter Cohort Study. Open Forum Infect Dis. 2020; 7(4):ofaa097. PMC: 7186524. DOI: 10.1093/ofid/ofaa097. View

Pfundstein J, Roghmann M, Schwalbe R, Qaiyumi S, McCarter Jr R, Keay S . A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients. Clin Transplant. 1999; 13(3):245-52. DOI: 10.1034/j.1399-0012.1999.130305.x. View

Saullo J, Miller R . Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients. Annu Rev Med. 2022; 74:89-105. DOI: 10.1146/annurev-med-042921-124739. View

Nelson J, Carrillo-Martin I, Bosch W, Brumble L, Oring J, Park M . Outcomes in hospitalized kidney transplant patients with a penicillin allergy label in the United States, 2005-2014. J Allergy Clin Immunol Pract. 2021; 10(3):867-869.e2. DOI: 10.1016/j.jaip.2021.10.015. View

Imlay H, Krantz E, Stohs E, Lan K, Zier J, Kim H . Reported β-Lactam and Other Antibiotic Allergies in Solid Organ and Hematopoietic Cell Transplant Recipients. Clin Infect Dis. 2019; 71(7):1587-1594. PMC: 8241219. DOI: 10.1093/cid/ciz1025. View

Copaescu A, Vogrin S, James F, Chua K, Rose M, De Luca J . Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial. JAMA Intern Med. 2023; 183(9):944-952. PMC: 10352926. DOI: 10.1001/jamainternmed.2023.2986. View

10.

Verlinden A, Mikulska M, Knelange N, Averbuch D, Styczynski J . Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey. Bone Marrow Transplant. 2020; 55(8):1588-1594. PMC: 7391284. DOI: 10.1038/s41409-020-0811-y. View

11.

Zhang H, Anesi J, Hamilton K, Cressman L, Bilker W, Lautenbach E . The Impact of Reported β-Lactam Allergy on Clinical Outcomes and Antibiotic Use Among Solid Organ Transplant Recipients. Open Forum Infect Dis. 2022; 9(8):ofac384. PMC: 9379814. DOI: 10.1093/ofid/ofac384. View

12.

Jorgenson M, Descourouez J, Wong C, Strayer J, Parajuli S, Rice J . Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies. Transpl Infect Dis. 2021; 23(4):e13586. PMC: 7995190. DOI: 10.1111/tid.13586. View

13.

So M, Tsai H, Swaminathan N, Bartash R . Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them. Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e72. PMC: 9726551. DOI: 10.1017/ash.2022.53. View

14.

Khawaja F, Spallone A, Kotton C, Chemaly R . Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium. Clin Microbiol Infect. 2022; 29(1):44-50. DOI: 10.1016/j.cmi.2022.07.001. View

15.

Escudero-Sanchez R, Muriel Garcia A, Garcia Fernandez S, Valencia Alijo A, Tasias Pitarch M, Merino de Lucas E . Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study. J Antimicrob Chemother. 2022; 77(7):1996-2002. DOI: 10.1093/jac/dkac106. View

16.

Aguilar-Guisado M, Espigado I, Martin-Pena A, Gudiol C, Royo-Cebrecos C, Falantes J . Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. Lancet Haematol. 2017; 4(12):e573-e583. DOI: 10.1016/S2352-3026(17)30211-9. View

17.

Abbo L, Grossi P . Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33(9):e13589. DOI: 10.1111/ctr.13589. View

18.

Chan S, Ng S, Chan H, Pascoe E, Playford E, Wong G . Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients. Cochrane Database Syst Rev. 2020; 8:CD013209. PMC: 7437398. DOI: 10.1002/14651858.CD013209.pub2. View

19.

Cohen J, Rees A, Williams G . A prospective randomized controlled trial of perioperative antibiotic prophylaxis in renal transplantation. J Hosp Infect. 1988; 11(4):357-63. DOI: 10.1016/0195-6701(88)90089-8. View

20.

Jorgenson M, Descourouez J, Kleiboeker H, Goldrosen K, Schulz L, Rice J . Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard. Transpl Infect Dis. 2022; 24(5):e13864. DOI: 10.1111/tid.13864. View